Connection
Thomas Meyer to Angiogenesis Inhibitors
This is a "connection" page, showing publications Thomas Meyer has written about Angiogenesis Inhibitors.
|
|
Connection Strength |
|
 |
|
 |
|
0.052 |
|
|
|
-
Traxler P, Allegrini PR, Brandt R, Brueggen J, Cozens R, Fabbro D, Grosios K, Lane HA, McSheehy P, Mestan J, Meyer T, Tang C, Wartmann M, Wood J, Caravatti G. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity. Cancer Res. 2004 Jul 15; 64(14):4931-41.
Score: 0.052